Vericel Corp
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table contains information regarding all repurchases of our common stock for the three months ended September 30, 2026:
| Period · Total Number of Shares Purchased · Average Price Paid per Share · Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1) · Approximate Dollar Value of Shares (in millions) that May Yet Be Purchased Under the Plans or Programs | |||||
|---|---|---|---|---|---|
| July 1, 2026 - July 31, 2026 | — | $— | — | $200.0 | |
| August 1, 2026 - August 31, 2026 | 46,829 | $41.74 | 46,829 | $198.0 | |
| September 1, 2026 - September 30, 2026 | 173,915 | $39.63 | 173,915 | $191.2 | |
| Total | 220,744 | 220,744 | |||
(1) On July 30, 2026, we announced the approval by our Board of Directors of repurchase authorization with no expiration date. Under this authorization, the Company may repurchase up to $200.0 million of outstanding shares of our common stock. The authorization allows for repurchases to be made in the open market, privately negotiated transactions, or otherwise, in accordance with applicable federal securities laws, including through Rule 10b5‐1 trading plans and under Rule 10b‐18 of the Securities Exchange Act of 1934, as amended.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.